Researchers have established that semaglutide, found in Ozempic and Wegovy, is linked to a 45 percent increased risk of suicidal thoughts compared to other diabetes medications.
The analysis reveals that semaglutide not only correlates with suicidal ideation but also with attempts, some of which were tragically successful—adding gravitas to anecdotal claims.
Experts caution that while the study indicates a link, it does not prove causation, urging doctors to exercise caution when prescribing semaglutide.
Governments, including the FDA, have so far not substantiated claims of a conclusive link between semaglutide and suicidal behaviors, suggesting more research is needed.
Collection
[
|
...
]